SOBRE ESTE EPISÓDIO
Dr Kavanagh, President-elect to the ASTRO board of directors, talks to ecancertv about the theme of ASTRO 2015 – Technology Meets Patient Care – and how the research and presentations being given relate to this.
In the interview he highlights research that is not only comparing the effectiveness of the different types of radiotherapy but also focussing on reducing the toxicity associated with radiation treatment.
Initiatives to improve patient care are not just about using the best available technology, he comments, it is also about optimising human resources and nursing care, and listening to patients.
Dr Kavanagh also comments on data showing that dexamethasone may reduce radiation-induced pain flares and on plans for ASCO 2016.
In the interview he highlights research that is not only comparing the effectiveness of the different types of radiotherapy but also focussing on reducing the toxicity associated with radiation treatment.
Initiatives to improve patient care are not just about using the best available technology, he comments, it is also about optimising human resources and nursing care, and listening to patients.
Dr Kavanagh also comments on data showing that dexamethasone may reduce radiation-induced pain flares and on plans for ASCO 2016.
Inglês
Estados Unidos da América
TRANSCRIÇÃO 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
PESQUISAR EPISÓDIOS PASSADOS
Pesquisar episódios anteriores de ASTRO 2015.
OUTROS EPISÓDIOS NESTE PODCAST
Dr Hong talks to ecancertv about one of the nursing sessions held at ASTRO 2015 that looked at the care of patients receiving chemoradiation.
In the interview he outlines that the aims of the session were to provide an overview of the data and rationale for why certain chemoradiation strategies we…
Dr Hoyer talks to ecancertv at ASTRO 2015 about his lecture during the ASTRO/ESTRO Joint Session 'Novel treatment approaches for oligometastases'.
In the interview he provides background on how oligometastases have been managed in the past and how stereotactic body radiation therapy (SBRT) is bein…
Dr Abazeed talks to ecancertv at ASTRO 2015 about research being conducted at the Cleveland Clinic looking at whether it is possible to use genomic parameters to predict how tumours will respond to radiation therapy.
In the interview he highlights that there is an underlying genetic diversity of c…
Dr Hong talks to ecancertv at ASTRO 2015 about a prospective, open-label phase II, study of proton-based stereotactic body radiotherapy (SBRT) in patients with liver metastases.
The study findings showed that proton SBRT was associated with high rates of local control and that there was a favourab…
Mr DiGiaimo talks to ecancertv at ASTRO 2015 about some of his research highlights and the potential economic considerations of using newer radiation technologies over conventional standards.
Aviso: O podcast e a arte incorporada nesta página são de ecancer.org, que é propriedade de seu proprietário e não é afiliado ou endossado por Listen Notes, Inc.
EDITAR
Obrigado por ajudar a manter a base de dados dos podcasts atualizada.
